The University of Kentucky Markey Cancer Center is an academic, clinical and research center located in Lexington, Kentucky. It was established in 1985, and has grown to 28 departments across eight colleges.

During the past decade, University of Kentucky Markey Cancer Center Clinical Research Organization conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Kentucky Markey Cancer Center Clinical Research Organization" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator and "Spanish Breast Cancer Research Group (SOLTI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "University of Kentucky Markey Cancer Center Clinical Research Organization" are "Neuroendocrine Tumors" (2 trials), "AML" (1 trials), "Bladder Cancer" (1 trials), "HER2-Positive Primary Breast Cancer" (1 trials) and "Hodgkin's Disease" (1 trials). Many other conditions were trialed in "University of Kentucky Markey Cancer Center Clinical Research Organization" in a lesser frequency.

Most popular intervention types in "University of Kentucky Markey Cancer Center Clinical Research Organization" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "CDX-1307 Vaccine Regimen" (1 trials), "Chemotherapy" (1 trials), "DS-8201a" (1 trials), "T-DM1" (1 trials) and "azacitidine" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Kentucky Markey Cancer Center Clinical Research Organization" are 5 trials for "All" genders.

Currently, there are NaN active trials in "University of Kentucky Markey Cancer Center Clinical Research Organization". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in University of Kentucky Markey Cancer Center Clinical Research Organization, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Kentucky Markey Cancer Center Clinical Research Organization, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".